Ignite Creation Date:
2024-05-06 @ 1:05 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03937895
Status:
COMPLETED
Last Update Posted:
2022-03-29
First Post:
2019-04-29
Brief Title:
Allogeneic NK Cell SMT-NK in Combination With Pembrolizumab in Advanced Biliary Tract Cancer
Sponsor:
SMT bio Co Ltd
Organization:
SMT bio Co Ltd
Organization Data
Organization:
SMT bio Co Ltd
Class:
INDUSTRY
Study ID:
SNK-SIT-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
SMT bio Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None